Amgen, Eli Lilly, Viking Therapeutics Shares Rise Pre-Bell After Novo Nordisk's Obesity Treatment Falls Short of Expectations
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
628.90 DKK | -0.96% |
|
+3.56% | +0.75% |
Feb. 07 | Novo Nordisk's Head of Research Marcus Schindler sells shares for DKK 25 million | FW |
Feb. 07 | Futures steady ahead of US jobs data, tariff reprieve | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration